title: Synthesis of antiproliferative Cephalotaxus esters and their evaluation against several human hematopoietic and solid tumor cell lines: uncovering differential susceptibilities to multidrug resistance.
abstract: Deoxyharringtonine (2), homoharringtonine (3), homodeoxyharringtonine (4), and anhydroharringtonine (5) are reported to be among the most potent members of the antileukemia alkaloids isolated from the Cephalotaxus genus. Convergent syntheses of these four natural products are described, each involving novel synthetic methods and strategies. These syntheses enabled evaluation of several advanced natural and non-natural compounds against an array of human hematopoietic and solid tumor cells. Potent cytotoxicity was observed in several cell lines previously not challenged with these alkaloids. Variations in the structure of the ester chain within this family of alkaloids confer differing activity profiles against vincristine-resistant HL-60/RV+, signalling new avenues for molecular design of these natural products to combat multi-drug resistance.
authors: Department of Chemistry, University of Illinois, Urbana, IL 61801, USA.
authors: Joseph D
authors: JD
authors: Eckelbarger
authors: Jeremy T
authors: JT
authors: Wilmot
authors: Matthew T
authors: MT
authors: Epperson
authors: Chandar S
authors: CS
authors: Thakur
authors: David
authors: D
authors: Shum
authors: Christophe
authors: C
authors: Antczak
authors: Leonid
authors: L
authors: Tarassishin
authors: Hakim
authors: H
authors: Djaballah
authors: David Y
authors: DY
authors: Gin
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000138:chemical synthesis* / Q000494:pharmacology*; D001388:Aziridines / Q000737:chemistry; D001552:Benzazepines / Q000138:chemical synthesis / Q000737:chemistry; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm; D004354:Drug Screening Assays, Antitumor; D004952:Esters / Q000138:chemical synthesis / Q000494:pharmacology; D006248:Harringtonines / Q000138:chemical synthesis* / Q000494:pharmacology*; D019337:Hematologic Neoplasms / Q000188:drug therapy; D000077863:Homoharringtonine; D006801:Humans; D012175:Retinoblastoma / Q000188:drug therapy
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D001388:Aziridines; D001552:Benzazepines; D004952:Esters; D006248:Harringtonines; D000077863:Homoharringtonine